AllianceBernstein’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65.2M Sell
377,701
-54,397
-13% -$9.39M 0.02% 539
2025
Q1
$67.3M Sell
432,098
-12,930
-3% -$2.02M 0.02% 497
2024
Q4
$61.3M Sell
445,028
-9,760
-2% -$1.34M 0.02% 538
2024
Q3
$67.9M Sell
454,788
-20,213
-4% -$3.02M 0.02% 523
2024
Q2
$64.8M Buy
475,001
+1,248
+0.3% +$170K 0.02% 535
2024
Q1
$71.6M Sell
473,753
-115,183
-20% -$17.4M 0.03% 504
2023
Q4
$74.2M Sell
588,936
-13,938
-2% -$1.76M 0.03% 486
2023
Q3
$56.5M Buy
602,874
+24,487
+4% +$2.29M 0.02% 524
2023
Q2
$51.6M Buy
578,387
+63,329
+12% +$5.65M 0.02% 565
2023
Q1
$55.2M Buy
515,058
+25,112
+5% +$2.69M 0.02% 536
2022
Q4
$59.8M Sell
489,946
-149,930
-23% -$18.3M 0.03% 521
2022
Q3
$66.1M Sell
639,876
-43,920
-6% -$4.54M 0.03% 470
2022
Q2
$63.6M Sell
683,796
-25,085
-4% -$2.33M 0.03% 495
2022
Q1
$83.2M Sell
708,881
-1,271
-0.2% -$149K 0.03% 455
2021
Q4
$95.5M Buy
710,152
+152,221
+27% +$20.5M 0.03% 452
2021
Q3
$88.9M Sell
557,931
-24,467
-4% -$3.9M 0.04% 456
2021
Q2
$76.6M Buy
582,398
+103,056
+21% +$13.6M 0.03% 511
2021
Q1
$61.8M Buy
479,342
+16,809
+4% +$2.17M 0.03% 539
2020
Q4
$77.1M Sell
462,533
-5,968
-1% -$995K 0.04% 451
2020
Q3
$72.3M Buy
468,501
+21,467
+5% +$3.31M 0.04% 432
2020
Q2
$66.1M Sell
447,034
-56,223
-11% -$8.32M 0.04% 452
2020
Q1
$56.7M Sell
503,257
-33,829
-6% -$3.81M 0.04% 404
2019
Q4
$74.7M Buy
537,086
+1,940
+0.4% +$270K 0.04% 417
2019
Q3
$51.5M Buy
535,146
+31,741
+6% +$3.06M 0.03% 514
2019
Q2
$58M Sell
503,405
-107,449
-18% -$12.4M 0.04% 498
2019
Q1
$71.9M Sell
610,854
-75,790
-11% -$8.92M 0.05% 409
2018
Q4
$43M Sell
686,644
-27,722
-4% -$1.74M 0.03% 519
2018
Q3
$50.6M Buy
714,366
+19,039
+3% +$1.35M 0.03% 517
2018
Q2
$46.3M Sell
695,327
-38,056
-5% -$2.53M 0.03% 537
2018
Q1
$48M Buy
733,383
+677,843
+1,220% +$44.3M 0.03% 494
2017
Q4
$2.23M Buy
55,540
+25,540
+85% +$1.02M ﹤0.01% 1771
2017
Q3
$1.09M Buy
+30,000
New +$1.09M ﹤0.01% 2222